Eurocine Vaccines is a pharmaceutical company. Today, the company develops vaccines for the treatment of influenza. The vaccine may be used by both adults and children and is applied through nasal drops rather than needle sticks. The products are sold under separate trademarks, and the largest business is found in the Nordic market, where research is carried out in cooperation with other companies in the industry. The head office is located in Solna.

Quotes for Eurocine Vaccines AB

Right Now

+/-
0.008
%
4,82%
Latest
0.174
High
0.189
Low
0.165
Volume
324 921
Turnover (SEK)
56 530
Value (MSEK)
14,8

Board

CEO

  • Hans Arwidsson

Chairman Of The Board

  • Michael Wolff Jensen

Board

  • Jan Sandström
  • Pär Thuresson
  • Pierre A. Morgon

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 6,27 6,27 2019-03-31
Nordnet Pensionsförsäkring 4,31 4,31 2019-03-31
Niclas Falk 2,00 2,00 2019-03-31
Kent Olsson 1,42 1,42 2019-03-31
Nordea Liv & Pension 1,30 1,30 2019-03-31
Hans Arwidsson 1,22 1,22 2018-12-07
Handelsbanken Liv Försäkring AB 1,07 1,07 2019-03-31
BRL Invest AB 1,06 1,06 2019-03-31
Björn Ljunggren 0,98 0,98 2019-03-31
Göran Erlandsson 0,96 0,96 2019-03-31
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Inquiry Financial